AurorA-TT is a Technology Transfer Intermediation Company established in 2017 based in Milan, Italy. We identify promising scientific breakthroughs from academia and research centers in Italy and partner with academia, research institutions and biotech companies based globally.
AurorA-TT invests in pre-seed and seed projects to bridge the gap between basic research and industrial drug development with industrial discipline.
Successful projects either become assets for the creation of stand-alone companies, partnership with financial investors, biotech and pharma companies, or translate into agreements of varying nature with synergic partners.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Via Dell'annunciata 31, Milano,20121,italy
- Phone
- +39-294758489
- in****@****-tt.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- aurora-tt.com
- Keywords
- Technology Transfer, Seed funding, Venture Capital, Drug discovery, Biotechnology, Research, Licensing, Life science.
- HQ
- Milano
Aurora-Tt Questions
Aurora-Tt's helpline number is +39-294758489
Aurora-Tt's website is aurora-tt.com
Aurora-Tt's LinkedIn profile is https://it.linkedin.com/company/aurora-tt
Aurora-Tt has
4 employees.
View email and phone details for 4
employees at Aurora-Tt.
Aurora-Tt's industry is
Biotechnology Research
Aurora-Tt's top competitors are
Celldynamics,
Molmed Now Part Of Agc Biologics,
Altheia Science,
Enthera Pharmaceuticals,
Cellply,
Resalis Therapeutics,
Generon S.p.a.,
Sibylla Biotech,
Genenta Science (Nasdaq: Gnta),
Agc Biologics.
Aurora-Tt's support email address is infodesk@aurora-tt.com
Aurora-Tt's categories are Biotechnology Research
Aurora-Tt's founding year is 2017
